Company intelligence / Profile preview

Daydream

Bala-Cynwyd, Pennsylvania, USA

Ownership: Private
Development stage: Preclinical

Overview

Daydream GmbH provides B2B market strategy and business development services across chemistry, biotechnology & life sciences sectors. It has completed over 400 projects since 2000 but does not itself develop therapeutics or diagnostics. Its value proposition centers on actionable insights for client growth objectives using proprietary analytical tools and methodologies.

Industry: Consulting

Partnerships

Works with clients such as BASF Europe and Total Marketing & Services as referenced in testimonials[1]

Beyond the preview

Go deeper on Daydream.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daydream.

Explore the full profile